Trials / Recruiting
RecruitingNCT07258069
Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)
Observational, Prospective, Multicenter Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 178 (estimated)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to proof the effectiveness of Histoacryl® on preventing recurrence or progression of subdural hematoma after embolization of the middle meningeal artery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Histoacryl® | Histoacryl® is used by direct needle puncture, transcatheter approach, or transendoscopic approach in vascular embolization for the described purposes. |
Timeline
- Start date
- 2026-04-10
- Primary completion
- 2026-12-01
- Completion
- 2027-08-01
- First posted
- 2025-12-02
- Last updated
- 2026-04-17
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT07258069. Inclusion in this directory is not an endorsement.